Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Joint venture to develop treatment for male impotence

Sep. 6, 1996

Bio-Technology General to seek approval for sublingual testosterone

Sep. 6, 1996

AGE-specific monoclonal antibody from Alteon

Sep. 6, 1996

Novo Nordisk licenses Scios' insulinotropin

Sep. 6, 1996

Location of gene linked to type 2 diabetes discovered

Sep. 6, 1996

Clinical results for Cortecs' oral insulin formulation

Sep. 6, 1996

Terumo pursues treatments for diabetes and complications

Sep. 6, 1996

Retinoid compound from Sparta enters U.S. clinical trials

Sep. 6, 1996

A new CETP inhibitor from Schering-Plough

Sep. 6, 1996

Japanese researchers describe natural lipid-lowering agents

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...